Q2-FY26 · Rupak Saraswat
Our IBITA is up 120 to 160 cr which is up 33%. And the IBITA margin is up 12.4% to 14.6%.
INDIAGLYCO / language trends
Read confidence between the lines.
India Glycols · tone and specificity signals across the available quarters.
Research layer active
Language signals
What changed in management language.
tracked
Q2-FY26 · Rupak Saraswat
We have also become the first ever company globally to make biobased amines whilst we are to start commercial sales in this quarter and the next quarter.
Q2-FY26 · Shukla
The understanding is very clear from a long-term perspective they have we have the first right of refusal even after a long-term once the agreements are there for renewal.
Q3-FY26 · Rupak Saraswat
We are the first company in the world to make the first commercial sale of biobased amines which we make to L'Oreal.
Q3-FY26 · SK Shukla
Our strategy is to establish our brands across segments particularly in whiskey segment. All our competitors most of them do not have whiskeys in the premium segment.
Q3-FY26 · Rupak Saraswat
We are going to see very strong growth this year both in terms of revenue as well as profit on a small base and I'm quite confident that we are going to see good growth in the years to come.